相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche
Olivier Govaere et al.
JOURNAL OF HEPATOLOGY (2016)
Molecular Mechanism and Prediction of Sorafenib Chemoresistance in Human Hepatocellular Carcinoma
Naoshi Nishida et al.
DIGESTIVE DISEASES (2015)
Focal adhesion signaling and therapy resistance in cancer
Iris Eke et al.
SEMINARS IN CANCER BIOLOGY (2015)
A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells
Joan Fernando et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment
Gianluigi Giannelli et al.
GUT (2014)
Stellate cells and the development of liver cancer: Therapeutic potential of targeting the stroma
Cedric Coulouarn et al.
JOURNAL OF HEPATOLOGY (2014)
Molecular Profiling of Stroma Identifies Osteopontin as an Independent Predictor of Poor Prognosis in Intrahepatic Cholangiocarcinoma
Laurent Sulpice et al.
HEPATOLOGY (2013)
Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
Josep M. Llovet et al.
CLINICAL CANCER RESEARCH (2012)
Pancreatic Stellate Cells Radioprotect Pancreatic Cancer Cells through β1-Integrin Signaling
Tine S. Mantoni et al.
CANCER RESEARCH (2011)
Hepatic stellate cells stimulate HCC cell migration via laminin-5 production
Angela Santamato et al.
CLINICAL SCIENCE (2011)
Disruption of Laminin-Integrin-CD151-Focal Adhesion Kinase Axis Sensitizes Breast Cancer Cells to ErbB2 Antagonists
Xiuwei H. Yang et al.
CANCER RESEARCH (2010)
Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
Douglas W. McMillin et al.
NATURE MEDICINE (2010)
Update on the pathophysiology of liver fibrosis
Massimo Pinzani et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Kandice R. Levental et al.
CELL (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Laminin-5 stimulates hepatocellular carcinoma growth through a different function of α6β4 and α3β1 integrins
Carlo Bergamini et al.
HEPATOLOGY (2007)
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
Li Liu et al.
CANCER RESEARCH (2006)
Cyclohexylpiperazine derivative PB28, a σ2 agonist and σ1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer
Amalia Azzariti et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Laminin-5 with transforming growth factor-β1 induces epithelial to mesenchymal transition in hepatocellular carcinoma
G Giannelli et al.
GASTROENTEROLOGY (2005)
Occurrence of portal vein tumor thrombus in hepatocellular carcinoma affects prognosis and survival. A retrospective clinical study of 150 cases
G Giannelli et al.
HEPATOLOGY RESEARCH (2002)
Transforming growth factor-β1 triggers hepatocellular carcinoma invasiveness via α3β1 integrin
G Giannelli et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Human hepatocellular carcinoma (HCC) cells require both α3β1 integrin and matrix metalloproteinases activity for migration and invasion
G Giannelli et al.
LABORATORY INVESTIGATION (2001)
Adhesion to fibronectin via β1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR)
LA Hazlehurst et al.
ONCOGENE (2000)
分享论文
